Christopher Heckman serves as the Vice President of Delivery at Fortrea, where he plays a pivotal role in shaping the strategic direction and operational execution of real-world intelligence and late-phase solutions for large pharmaceutical clients. With a robust background in both strategic and business development,...
Christopher Heckman serves as the Vice President of Delivery at Fortrea, where he plays a pivotal role in shaping the strategic direction and operational execution of real-world intelligence and late-phase solutions for large pharmaceutical clients. With a robust background in both strategic and business development, Christopher leverages his extensive expertise in clinical trials, regulatory submissions, and project portfolio management to drive impactful outcomes in the pharmaceutical and biotech industries. His leadership in managing complex client relationships has been instrumental in enhancing Fortrea's reputation as a trusted partner in clinical research.
In his current role, Christopher oversees a diverse range of key projects that focus on integrating real-world evidence into clinical development pathways, thereby optimizing drug development processes and improving patient outcomes. His proficiency in electronic data capture (EDC) and clinical data management ensures that Fortrea remains at the forefront of innovation, providing clients with actionable insights that inform decision-making and regulatory strategies. Christopher's commitment to adhering to ICH-GCP guidelines and maintaining compliance with FDA regulations underscores his dedication to quality and integrity in clinical research.
With a strong foundation as a BSN/RN and a Master’s degree, Christopher combines clinical knowledge with strategic acumen, making him a valuable asset in the ever-evolving landscape of life sciences. His ability to navigate the complexities of CRO management and clinical monitoring further enhances Fortrea's capabilities, positioning the company as a leader in delivering comprehensive solutions tailored to the needs of large pharma clients. Through his visionary leadership, Christopher continues to drive Fortrea’s mission of advancing healthcare through innovative research and development initiatives.
